Search Results For ''

  • One Click Group flooded with customers desperate for FY24 tax refunds

    With Australians fighting the cost-of-living financial squeeze created by the Reserve Bank, One Click Group (ASX: 1CG) has seen a surge in customer demand for their Next Day Refund product within the first 2 days of FY24 ending, enticed by the swift turnaround on tax refunds.  The Next Day Refund product, which debuted last financial

    Read More
    Public
  • XJO to rise as US shares set fresh records

    The XJO is expected to edge higher on open this morning following a U.S which managed to finish in all-time highs. Their market is still arguably trading in a tight range and so our market is likely skeptical of their rise. Yesterday we held towards the day’s lows into the close. We continue to grind

    Read More
    Public
  • Melodiol Global Health reports revenue growth amid wider acceptance of medicinal cannabis products

    Recreational cannabis use has been a global topic for debate in the past few years but cannabinoids, a naturally occurring compound in cannabis, are now gaining momentum as a treatment for managing pain, inflammation and various mental health conditions like depression and PTSD. For the past several months, Melodiol Global Health’s (ASX: ME1) subsidiary, Health

    Read More
    Public
  • SDI reports profit upgrade with cost cutting measure proving effective

    Dental products manufacturer SDI Limited (ASX: SDI), has announced an uplift in expected profit for FY24, following a range of operational initiatives announced four months ago to reduce operating expenses.  SDI’s preliminary sales for FY24 (unaudited) revealed a 3.2% increase to $111.4 million, compared to $107.9 million in the previous year, marking a record twelve-month

    Read More
    Public
  • Mayne Pharma settles shareholder class action for $38M with no admission of guilt

    A standoff with shareholders dating back to 2014 has finally ended with Mayne Pharma (ASX: MYX) agreeing to settle a class action brought against them from shareholders, centering around allegations of misleading and deceptive conduct by the pharma company.  The origins of the class action trace back to investigations by the US Department of Justice

    Read More
    Public
  • XJO to open lower with Tech holding up US markets

    The XJO is expected to edge lower on open this morning following another lackluster night of sidewards movement from the U.S. Their futures have also edged into the red. Yesterday we kept in step with the past few sessions. Our market once again tried to move away from the middle of the range, but retraced

    Read More
    Public